Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency
详细信息 查看全文
- 作者：Latha Soorya (1) (13) (2)
Alexander Kolevzon (1) (2) (3)
Jessica Zweifach (1)
Teresa Lim (2)
Yuriy Dobry (2)
Lily Schwartz (1)
Yitzchak Frank (1) (2) (3) (4)
A Ting Wang (1) (2) (5)
Guiqing Cai (1) (2) (6)
Elena Parkhomenko (1) (2)
Danielle Halpern (1) (2)
David Grodberg (1) (2)
Benjamin Angarita (2)
Judith P Willner (3) (6)
Amy Yang (3) (6)
Roberto Canitano (1) (14)
William Chaplin (8)
Catalina Betancur (10) (11) (9)
Joseph D Buxbaum (1) (12) (2) (5) (6) (7) - 关键词：22q13 deletion syndrome ; Autism ; Microarrays ; Mutation ; Phelan ; McDermid syndrome ; SHANK3
- 刊名：Molecular Autism
- 出版年：2013
- 出版时间：December 2013
- 年：2013
- 卷：4
- 期：1
- 全文大小：526KB
- 参考文献：1. Phelan K, Rogers C: Phelan-McDermid Syndrome. / GeneReviews 2011. [http://wwwncbinlmnihgov/books/NBK1198/]
2. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckarsater H, Sponheim E, Goubran-Botros H, Delorme R, Chabane N, Mouren-Simeoni MC, de Mas P, Bieth E, Roge B, Heron D, Burglen L, Gillberg C, Leboyer M, Bourgeron T: Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. / Nat Genet 2007, 39:25鈥?7. CrossRef
3. Moessner R, Marshall CR, Sutcliffe JS, Skaug J, Pinto D, Vincent J, Zwaigenbaum L, Fernandez B, Roberts W, Szatmari P, Scherer SW: Contribution of SHANK3 mutations to autism spectrum disorder. / Am J Hum Genet 2007, 81:1289鈥?297. CrossRef
4. Gauthier J, Spiegelman D, Piton A, Lafreniere RG, Laurent S, St-Onge J, Lapointe L, Hamdan FF, Cossette P, Mottron L, Fombonne E, Joober R, Marineau C, Drapeau P, Rouleau GA: Novel de novo SHANK3 mutation in autistic patients. / Am J Med Genet B Neuropsychiatr Genet 2009, 150B:421鈥?24. CrossRef
5. Bonaglia MC, Giorda R, Beri S, De Agostini C, Novara F, Fichera M, Grillo L, Galesi O, Vetro A, Ciccone R, Bonati MT, Giglio S, Guerrini R, Osimani S, Marelli S, Zucca C, Grasso R, Borgatti R, Mani E, Motta C, Molteni M, Romano C, Greco D, Reitano S, Baroncini A, Lapi E, Cecconi A, Arrigo G, Patricelli MG, Pantaleoni C, / et al.: Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan/McDermid syndrome. / PLoS Genet 2011, 7:e1002173. CrossRef
6. Boeckers TM: The postsynaptic density. / Cell Tissue Res 2006, 326:409鈥?22. CrossRef
7. Schaaf CP, Sabo A, Sakai Y, Crosby J, Muzny D, Hawes A, Lewis L, Akbar H, Varghese R, Boerwinkle E, Gibbs RA, Zoghbi HY: Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. / Hum Mol Genet 2011, 20:3366鈥?375. CrossRef
8. Boccuto L, Lauri M, Sarasua SM, Skinner CD, Buccella D, Dwivedi A, Orteschi D, Collins JS, Zollino M, Visconti P, Dupont B, Tiziano D, Schroer RJ, Neri G, Stevenson RE, Gurrieri F, Schwartz CE: Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. / Eur J Hum Genet 2013, 21:310鈥?16. CrossRef
9. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B, Yoon S, Krasnitz A, Kendall J, Leotta A, Pai D, Zhang R, Lee YH, Hicks J, Spence SJ, Lee AT, Puura K, Lehtimaki T, Ledbetter D, Gregersen PK, Bregman J, Sutcliffe JS, Jobanputra V, Chung W, Warburton D, King MC, Skuse D, Geschwind DH, Gilliam TC, / et al.: Strong association of de novo copy number mutations with autism. / Science 2007, 316:445鈥?49. CrossRef
10. Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, Drouin-Garraud V, Layet V, Rosier A, Briault S, Bonnet-Brilhault F, Laumonnier F, Odent S, Le Vacon G, Joly-Helas G, David V, Bendavid C, Pinoit JM, Henry C, Impallomeni C, Germano E, Tortorella G, Di Rosa G, Barthelemy C, Andres C, Faivre L, Frebourg T, Saugier Veber P, Campion D: Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. / Arch Gen Psychiatry 2009, 66:947鈥?56. CrossRef
11. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, Almeida J, Bacchelli E, Bader GD, Bailey AJ, Baird G, Battaglia A, Berney T, Bolshakova N, Bolte S, Bolton PF, Bourgeron T, Brennan S, Brian J, Bryson SE, Carson AR, Casallo G, Casey J, Chung BH, Cochrane L, Corsello C, / et al.: Functional impact of global rare copy number variation in autism spectrum disorders. / Nature 2010, 466:368鈥?72. CrossRef
12. Rosenfeld JA, Ballif BC, Torchia BS, Sahoo T, Ravnan JB, Schultz R, Lamb A, Bejjani BA, Shaffer LG: Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelopmental disorders. / Genet Med 2010, 12:694鈥?02. CrossRef
13. Shen Y, Dies KA, Holm IA, Bridgemohan C, Sobeih MM, Caronna EB, Miller KJ, Frazier JA, Silverstein I, Picker J, Weissman L, Raffalli P, Jeste S, Demmer LA, Peters HK, Brewster SJ, Kowalczyk SJ, Rosen-Sheidley B, McGowan C, Duda AW 3rd, Lincoln SA, Lowe KR, Schonwald A, Robbins M, Hisama F, Wolff R, Becker R, Nasir R, Urion DK, Milunsky JM, / et al.: Clinical genetic testing for patients with autism spectrum disorders. / Pediatrics 2010, 125:e727鈥?35. CrossRef
14. Bremer A, Giacobini M, Eriksson M, Gustavsson P, Nordin V, Fernell E, Gillberg C, Nordgren A, Uppstromer A, Anderlid BM, Nordenskjold M, Schoumans J: Copy number variation characteristics in subpopulations of patients with autism spectrum disorders. / Am J Med Genet B Neuropsychiatr Genet 2011, 156:115鈥?24. CrossRef
15. Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, Moreno-De-Luca D, Chu SH, Moreau MP, Gupta AR, Thomson SA, Mason CE, Bilguvar K, Celestino-Soper PB, Choi M, Crawford EL, Davis L, Wright NR, Dhodapkar RM, DiCola M, DiLullo NM, Fernandez TV, Fielding-Singh V, Fishman DO, Frahm S, Garagaloyan R, Goh GS, Kammela S, Klei L, Lowe JK, Lund SC, / et al.: Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. / Neuron 2011, 70:863鈥?85. CrossRef
16. Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, Williams C, Stalker H, Hamid R, Hannig V, Abdel-Hamid H, Bader P, McCracken E, Niyazov D, Leppig K, Thiese H, Hummel M, Alexander N, Gorski J, Kussmann J, Shashi V, Johnson K, Rehder C, Ballif BC, Shaffer LG, Eichler EE: A copy number variation morbidity map of developmental delay. / Nat Genet 2011, 43:838鈥?46. CrossRef
17. Gong X, Jiang YW, Zhang X, An Y, Zhang J, Wu Y, Wang J, Sun Y, Liu Y, Gao X, Shen Y, Wu X, Qiu Z, Jin L, Wu BL, Wang H: High proportion of 22q13 deletions and SHANK3 mutations in Chinese patients with intellectual disability. / PLoS One 2012, 7:e34739. CrossRef
18. Hamdan FF, Gauthier J, Araki Y, Lin DT, Yoshizawa Y, Higashi K, Park AR, Spiegelman D, Dobrzeniecka S, Piton A, Tomitori H, Daoud H, Massicotte C, Henrion E, Diallo O, Shekarabi M, Marineau C, Shevell M, Maranda B, Mitchell G, Nadeau A, D'Anjou G, Vanasse M, Srour M, Lafreniere RG, Drapeau P, Lacaille JC, Kim E, Lee JR, Igarashi K, / et al.: Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. / Am J Hum Genet 2011, 88:306鈥?16. CrossRef
19. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE, Stone EF, Chen C, Fak JJ, Chi SW, Licatalosi DD, Richter JD, Darnell RB: FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. / Cell 2011, 146:247鈥?61. CrossRef
20. Sakai Y, Shaw CA, Dawson BC, Dugas DV, Al-Mohtaseb Z, Hill DE, Zoghbi HY: Protein interactome reveals converging molecular pathways among autism disorders. / Sci Transl Med 2011, 3:86ra49. CrossRef
21. Nesslinger NJ, Gorski JL, Kurczynski TW, Shapira SK, Siegel-Bartelt J, Dumanski JP, Cullen RF Jr, French BN, McDermid HE: Clinical, cytogenetic, and molecular characterization of seven patients with deletions of chromosome 22q13.3. / Am J Hum Genet 1994, 54:464鈥?72.
22. Phelan MC, Rogers RC, Saul RA, Stapleton GA, Sweet K, McDermid H, Shaw SR, Claytor J, Willis J, Kelly DP: 22q13 deletion syndrome. / Am J Med Genet 2001, 101:91鈥?9. CrossRef
23. Luciani JJ, de Mas P, Depetris D, Mignon-Ravix C, Bottani A, Prieur M, Jonveaux P, Philippe A, Bourrouillou G, de Martinville B, Delobel B, Vallee L, Croquette MF, Mattei MG: Telomeric 22q13 deletions resulting from rings, simple deletions, and translocations: cytogenetic, molecular, and clinical analyses of 32 new observations. / J Med Genet 2003, 40:690鈥?96. CrossRef
24. Manning MA, Cassidy SB, Clericuzio C, Cherry AM, Schwartz S, Hudgins L, Enns GM, Hoyme HE: Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum. / Pediatrics 2004, 114:451鈥?57. CrossRef
25. Jeffries AR, Curran S, Elmslie F, Sharma A, Wenger S, Hummel M, Powell J: Molecular and phenotypic characterization of ring chromosome 22. / Am J Med Genet A 2005, 137:139鈥?47.
26. Koolen DA, Reardon W, Rosser EM, Lacombe D, Hurst JA, Law CJ, Bongers EM, van Ravenswaaij-Arts CM, Leisink MA, van Kessel AG, Veltman JA, de Vries BB: Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation. / Eur J Hum Genet 2005, 13:1019鈥?024. CrossRef
27. Philippe A, Boddaert N, Vaivre-Douret L, Robel L, Danon-Boileau L, Malan V, De Blois MC, Heron D, Colleaux L, Golse B, Zilbovicius M, Munnich A: Neurobehavioral profile and brain imaging study of the 22q13.3 deletion syndrome in childhood. / Pediatrics 2008, 122:e376鈥?82. CrossRef
28. Dhar SU, del Gaudio D, German JR, Peters SU, Ou Z, Bader PI, Berg JS, Blazo M, Brown CW, Graham BH, Grebe TA, Lalani S, Irons M, Sparagana S, Williams M, Phillips JA 3rd, Beaudet AL, Stankiewicz P, Patel A, Cheung SW, Sahoo T: 22q13.3 deletion syndrome: clinical and molecular analysis using array CGH. / Am J Med Genet A 2010, 152A:573鈥?81. CrossRef
29. Sarasua SM, Dwivedi A, Boccuto L, Rollins JD, Chen CF, Rogers RC, Phelan K, DuPont BR, Collins JS: Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome). / J Med Genet 2011, 48:761鈥?66. CrossRef
30. Denayer A, Van Esch H, de Ravel T, Frijns JP, Van Buggenhout G, Vogels A, Devriendt K, Geutjens J, Thiry P, Swillen A: Neuropsychopathology in 7 patients with the 22q13 deletion syndrome: presence of bipolar disorder and progressive loss of skills. / Mol Syndromol 2012, 3:14鈥?0.
31. Prasad C, Prasad AN, Chodirker BN, Lee C, Dawson AK, Jocelyn LJ, Chudley AE: Genetic evaluation of pervasive developmental disorders: the terminal 22q13 deletion syndrome may represent a recognizable phenotype. / Clin Genet 2000, 57:103鈥?09. CrossRef
32. Berument SK, Rutter M, Lord C, Pickles A, Bailey A: Autism screening questionnaire: diagnostic validity. / Br J Psychiatry 1999, 175:444鈥?51. CrossRef
33. Cusmano-Ozog K, Manning MA, Hoyme HE: 22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay. / Am J Med Genet C Semin Med Genet 2007, 145C:393鈥?98. CrossRef
34. Lord C, Rutter M, Le Couteur A: Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. / J Autism Dev Disord 1994, 24:659鈥?85. CrossRef
35. Gotham K, Bishop SL, Lord C: Diagnosis of Autism Spectrum Disorders. In / Autism Spectrum Disorders. Edited by: Amaral D, Geschwind D, Dawson G. New York: Oxford University Press; 2011:30鈥?3. CrossRef
36. Aldinger KA, Kogan J, Kimonis V, Fernandez B, Horn D, Klopocki E, Chung B, Toutain A, Weksberg R, Millen KJ, Barkovich AJ, Dobyns WB: Cerebellar and posterior fossa malformations in patients with autism-associated chromosome 22q13 terminal deletion. / Am J Med Genet A 2013, 161A:131鈥?36.
37. American Psychiatric Association: / Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Association; 2000.
38. Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC, Pickles A, Rutter M: The Autism Diagnostic Observation Schedule-Generic: a standard measure of social and communication deficits associated with the spectrum of autism. / J Autism Dev Disord 2000, 30:205鈥?23. CrossRef
39. Mullen EM: / Mullen Scales of Early Learning. Circle Pines, MN: American Guidance Service; 1995.
40. Roid GH: / Stanford-Binet Intelligence Scales. 5th edition. Itasca, IL: Riverside; 2003.
41. Roid GH, Miller LJ: / Leiter International Performance Scale-Revised. Wood Dale, IL: Stoelting Co.; 1997.
42. Sparrow SS, Cicchetti DV, Balla DA: / Vineland-II Survey Forms Manual (Vineland Adaptive Behavior Scales). 2nd edition. Minneapolis, MN: AGS Publishing; 2005.
43. Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF, Hakonarson H, Bucan M: PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. / Genome Res 2007, 17:1665鈥?674. CrossRef
44. Kolevzon A, Cai G, Soorya L, Takahashi N, Grodberg D, Kajiwara Y, Willner JP, Tryfon A, Buxbaum JD: Analysis of a purported SHANK3 mutation in a boy with autism: clinical impact of rare variant research in neurodevelopmental disabilities. / Brain Res 2011, 1380:98鈥?05. CrossRef
45. Brandt T, Desai K, Grodberg D, Mehta L, Cohen N, Tryfon A, Kolevzon A, Soorya L, Buxbaum JD, Edelmann L: Complex autism spectrum disorder in a patient with a 17q12 microduplication. / Am J Med Genet A 2012, 158A:1170鈥?177. CrossRef
46. Gotham K, Pickles A, Lord C: Standardizing ADOS scores for a measure of severity in autism spectrum disorders. / J Autism Dev Disord 2009, 39:693鈥?05. CrossRef
47. Szatmari P, Georgiades S, Bryson S, Zwaigenbaum L, Roberts W, Mahoney W, Goldberg J, Tuff L: Investigating the structure of the restricted, repetitive behaviours and interests domain of autism. / J Child Psychol Psychiatry 2006, 47:582鈥?90. CrossRef
48. Grodberg D, Weinger PM, Kolevzon A, Soorya L, Buxbaum JD: Brief report: the Autism Mental Status Examination: development of a brief autism-focused exam. / J Autism Dev Disord 2012, 42:455鈥?59. CrossRef
49. Phelan MC: Deletion 22q13.3 syndrome. / Orphanet J Rare Dis 2008, 3:14. CrossRef
50. Phelan K, McDermid HE: The 22q13.3 deletion syndrome (Phelan-McDermid syndrome). / Mol Syndromol 2012, 2:186鈥?01.
51. Rollins JD, Sarasua SM, Phelan K, DuPont BR, Rogers RC, Collins JS: Growth in Phelan-McDermid syndrome. / Am J Med Genet A 2011, 155A:2324鈥?326.
52. Risi S, Lord C, Gotham K, Corsello C, Chrysler C, Szatmari P, Cook EH Jr, Leventhal BL, Pickles A: Combining information from multiple sources in the diagnosis of autism spectrum disorders. / J Am Acad Child Adolesc Psychiatry 2006, 45:1094鈥?103. CrossRef
53. Schopler E, Reichler RJ, Renner BR: / The Childhood Autism Rating Scale. Los Angeles: Western Psychological Services; 1988.
54. Redecker P, Bockmann J, Bockers TM: Expression of postsynaptic density proteins of the ProSAP/Shank family in the thymus. / Histochem Cell Biol 2006, 126:679鈥?85. CrossRef
55. Chen CP, Lin SP, Chern SR, Tsai FJ, Wu PC, Lee CC, Chen YT, Chen WL, Wang W: A de novo 7.9 Mb deletion in 22q13.2-qter in a boy with autistic features, epilepsy, developmental delay, atopic dermatitis and abnormal immunological findings. / Eur J Med Genet 2010, 53:329鈥?32. CrossRef
56. Tufano M, Della Corte C, Cirillo F, Spagnuolo MI, Candusso M, Melis D, Torre G, Iorio R: Fulminant autoimmune hepatitis in a girl with 22q13 deletion syndrome: a previously unreported association. / Eur J Pediatr 2009, 168:225鈥?27. CrossRef
57. Vucurovic K, Landais E, Delahaigue C, Eutrope J, Schneider A, Leroy C, Kabbaj H, Motte J, Gaillard D, Rolland AC, Doco-Fenzy M: Bipolar affective disorder and early dementia onset in a male patient with SHANK3 deletion. / Eur J Med Genet 2012, 55:625鈥?29. CrossRef
58. Willemsen MH, Rensen JH, Van Schrojenstein-Lantman De Valk HM, Hamel BC, Kleefstra T: Adult phenotypes in Angelman- and Rett-like syndromes. / Mol Syndromol 2012, 2:217鈥?34.
59. Verhoeven WM, Egger JI, Willemsen MH, de Leijer GJ, Kleefstra T: Phelan-McDermid syndrome in two adult brothers: atypical bipolar disorder as its psychopathological phenotype? / Neuropsychiatr Dis Treat 2012, 8:175鈥?79. CrossRef
60. Wilson HL, Wong AC, Shaw SR, Tse WY, Stapleton GA, Phelan MC, Hu S, Marshall J, McDermid HE: Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. / J Med Genet 2003, 40:575鈥?84. CrossRef - 作者单位：Latha Soorya (1) (13) (2)
Alexander Kolevzon (1) (2) (3)
Jessica Zweifach (1)
Teresa Lim (2)
Yuriy Dobry (2)
Lily Schwartz (1)
Yitzchak Frank (1) (2) (3) (4)
A Ting Wang (1) (2) (5)
Guiqing Cai (1) (2) (6)
Elena Parkhomenko (1) (2)
Danielle Halpern (1) (2)
David Grodberg (1) (2)
Benjamin Angarita (2)
Judith P Willner (3) (6)
Amy Yang (3) (6)
Roberto Canitano (1) (14)
William Chaplin (8)
Catalina Betancur (10) (11) (9)
Joseph D Buxbaum (1) (12) (2) (5) (6) (7)
1. Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY, USA
13. Department of Psychiatry, Rush University Medical Center, Chicago, IL, USA
2. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
3. Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA
4. Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
5. Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA
6. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
14. Division of Child Neuropsychiatry, General University Hospital of Siena, Siena, Italy
8. Department of Psychology, St John鈥檚 University, Jamaica, NY, USA
10. CNRS UMR 7224, Paris, France
11. Universit茅 Pierre et Marie Curie, Paris, France
9. INSERM U952, Paris, France
12. Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
7. Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
文摘
Background 22q13 deletion syndrome, also known as Phelan-McDermid syndrome, is a neurodevelopmental disorder characterized by intellectual disability, hypotonia, delayed or absent speech, and autistic features. SHANK3 has been identified as the critical gene in the neurological and behavioral aspects of this syndrome. The phenotype of SHANK3 deficiency has been described primarily from case studies, with limited evaluation of behavioral and cognitive deficits. The present study used a prospective design and inter-disciplinary clinical evaluations to assess patients with SHANK3 deficiency, with the goal of providing a comprehensive picture of the medical and behavioral profile of the syndrome. Methods A serially ascertained sample of patients with SHANK3 deficiency (n = 32) was evaluated by a team of child psychiatrists, neurologists, clinical geneticists, molecular geneticists and psychologists. Patients were evaluated for autism spectrum disorder using the Autism Diagnostic Interview-Revised and the Autism Diagnostic Observation Schedule-G. Results Thirty participants with 22q13.3 deletions ranging in size from 101 kb to 8.45 Mb and two participants with de novo SHANK3 mutations were included. The sample was characterized by high rates of autism spectrum disorder: 27 (84%) met criteria for autism spectrum disorder and 24 (75%) for autistic disorder. Most patients (77%) exhibited severe to profound intellectual disability and only five (19%) used some words spontaneously to communicate. Dysmorphic features, hypotonia, gait disturbance, recurring upper respiratory tract infections, gastroesophageal reflux and seizures were also common. Analysis of genotype-phenotype correlations indicated that larger deletions were associated with increased levels of dysmorphic features, medical comorbidities and social communication impairments related to autism. Analyses of individuals with small deletions or point mutations identified features related to SHANK3 haploinsufficiency, including ASD, seizures and abnormal EEG, hypotonia, sleep disturbances, abnormal brain MRI, gastroesophageal reflux, and certain dysmorphic features. Conclusions This study supports findings from previous research on the severity of intellectual, motor, and speech impairments seen in SHANK3 deficiency, and highlights the prominence of autism spectrum disorder in the syndrome. Limitations of existing evaluation tools are discussed, along with the need for natural history studies to inform clinical monitoring and treatment development in SHANK3 deficiency.